Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease.
Navis
G
G
Groningen Institute of Drug Studies (GIDS), Department of Medicine, The Netherlands.
Buter
H
H
de Jong
P E
PE
Dullaart
R P
RP
de Zeeuw
D
D
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol